Vanessa Wolfeler

Just like how every software company is being asked what their AI strategy is, I believe every healthcare provider will be asked what their GLP-1 treatment strategy is. Reducing obesity is one of the most impactful things that can be done to improve society's health.

41

2 Comments

This content is intended for U.S. audiences only. The countdown to Chicago is on, as we gear up for #ASCO24 in less than two weeks! For the first time, @AstraZeneca will headline not one, but TWO back-to-back plenary sessions in LUNG as well as a late-breaking study in BREAST. Our team is focused on treating cancers at earlier stages and across subtypes while advancing medicines and combination therapies that attack the disease from all angles, evidenced by our strong, diverse research to be presented in Chicago. Behind every data point is a patient, who deserves a personalised therapy that will give them a longer and healthier life. For each one, we’re pushing the boundaries of science, and I can’t wait to highlight our research advances in the coming weeks. Stay tuned! 🔬 For a more detailed preview of our #ASCO24 data presentations, please see our press release https://lnkd.in/ehH7tqFc #CancerResearch #oncology #MedicalAdvancements

224

3 Comments

Ever felt the ripple effect of a political decision made thousands of miles away? At Traumen & Medisynq, we navigate these waters regularly, ensuring that global shifts don't derail our mission to provide affordable healthcare. Global events, like sudden trade changes, can swiftly alter our course, impacting how we deliver medicines worldwide. Recently, new trade barriers unexpectedly limited our access to essential materials. This challenge threatened not just our operations but the timely delivery of affordable medicines. We quickly adapted by adjusting our production methods, ensuring that our patients continued to receive their medications without interruption. These experiences teach us the importance of being prepared and proactive. In pharma, anticipating global shifts and planning for them is crucial for keeping our commitment to global healthcare. Have you faced challenges at work due to global events? #GlobalPolitics #PharmaLeadership #SupplyChainResilience #HealthcareInnovation #BusinessAgility

3

Since the first edition, Frontiers Health has been proudly supporting hundreds of emerging start-ups as well as later stage scale-ups in their pursuit to transform healthcare by helping not only to fund raise but also to make fruitful business connections.   Over the years we enjoyed bringing on stage many innovative companies, including mySugr, Kaia Health, Noom, Click Therapeutics, Inc., Akili, Big Health, Oviva, Altibbi, Biofourmis, HelloBetter, Medbelle, Doctolib, Caresyntax, Lindus Health, Kaiku Health just to mention a few.   We are delighted to announce that application for the 2024 edition of the Start-up and Scale-up Discovery sessions is now open.   Applications are welcome from both established and scaling companies as well as earlier stage, innovative and in-market, very high potential companies.   These sessions aim to connect these companies with investors and industry decision makers. As always, selected companies will present to a panel of leading investors which help to clarify the value proposition through a Q&A time at the end of each presentation.   Moreover, the application gives access to plenty of networking and curated meetings which is a great opportunity to connect with leading companies in the pharmaceutical, medical device, insurance, and healthcare delivery space at a decision-making level!   Seed to Series B stage start-ups and scale-up are welcome to apply on the R2GConnect platform by end of July https://lnkd.in/diutaRgs #FH24 #startup #healthinnovation #callforapplications #virtualcare #AI #MentalHealth #DTx #precisionmedicine #femtech

48

4 Comments

TLDR Biotech for June 27 - 30 𝐀𝐩𝐩𝐫𝐨𝐯𝐚𝐥𝐬: AstraZeneca, Sanofi's infant RSV vaccine gets thumbs-up from German vaccine advisory panel 💉 + 3 more stories 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭: Lantheus purchases two radiopharmaceutical assets from Life Molecular Imaging 💼 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬: J&J touts stellar Ph3 myasthenia gravis results 🧪 + 1 more story 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐋𝐚𝐮𝐧𝐜𝐡𝐞𝐬: Ensho Therapeutics launches with assets acquired from Eisai 🚀 𝐅𝐮𝐧𝐝𝐫𝐚𝐢𝐬𝐞𝐬: Savara $100M underwritten offering 💰 + 2 more stories 𝐋𝐚𝐰𝐬𝐮𝐢𝐭𝐬: Daiichi-Sankyo wins patent dispute against Seagen (Pfizer) ⚖️ 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬: Analysts predict change in Osteoporosis market winds; Amgen punching air 📊 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐀𝐜𝐜𝐞𝐬𝐬: CMS provides details on cell & gene therapy access pilot 🏥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲: Supreme Court overturns Chevron doctrine, potential FDA ramifications 🏛️ All this and more in today's TLDR Biotech newsletter - link to the latest issue: https://lnkd.in/gign9-Sw Or subscribe to get it straight to your inbox: https://lnkd.in/gh68uhTQ #tldrbiotech #biotechnews #pharmanews

11

A nice short HBR read as we are trying to modernize our ways of working, drive thoughtful risk taking and empower our talents for more innovation, more value creation — Many thanks Jasmine Chang for sharing !

52

2 Comments

The Engaging with Purpose Patient Engagement Framework seen below is based on a Twitter analysis of patient engagement. Our CONNECT Communications approach models this framework and values this type of research supporting patient engagement and participation. We are proud to support and promote active collaboration from industry, providers and patients. https://lnkd.in/g9qVM9pZ #healthcarecollaborators #patientengagement

11

Here's an urgent call to action: It's 2024 and still, inclusive health research is lagging. Demand Diversity is stepping in to initiate a powerful change. Our first mission on our relaunch? Making health research more inclusive for the LGBTQIA+ community. Imagine a world where healthcare is shaped by diverse minds, harnessing the varied life experiences of us all. Let's boost our support for LGBTQIA+ inclusivity, not tomorrow, but today. Discover our top 5 strategies for LGBTQIA+ inclusive healthcare at https://lnkd.in/eRD-nuaT Enough of just talk. It's time to walk the walk. How will you champion diversity in your work today? #DemandDiversity #InclusiveResearch #ClinicalTrialDiversity

14

I came across this interesting article about how to improve your prompts in ChatGPT. I hope you find it useful. https://lnkd.in/ehiAnchW

4

There are many reasons for women not being able to prioritize their own health or prevention. We developed solutions to remove some of the key barriers. This article equips you with knowledge and the latest innovative solutions for cervical cancer screening. I hope more women can be in charge of their own health.

24

Social determinants of health (SDOH) are becoming increasingly crucial in our already complex healthcare environment from a data collection, reporting, and action perspective. This week I’m sharing a link to a white paper I wrote about how patient service programs can incorporate actionable, tactical, and scalable solutions to help address SDOH challenges, advance health equity, and achieve better health outcomes for patients. Let’s connect if you’d like to discuss more… https://lnkd.in/ect4H9N3

31

Adding "O" for Obesity to ABCDES in Diabetes Management: Focusing on Upstream Approaches! In diabetes management, the traditional ABCDES framework has long been a cornerstone. It’s time to introduce a critical component: “O” for “Obesity.” Addressing obesity early and effectively is key to preventing diabetes and managing its progression, shifting towards upstream approaches that tackle the root causes. Why Focus on Obesity? Obesity is a major risk factor for type 2 diabetes. By targeting obesity, we can significantly reduce the incidence and severity of diabetes. Early intervention in obesity management can lead to better long-term health outcomes and reduce the burden on healthcare systems. Ania Jastreboff, MD, PhD #ADASciSessions #ADA2024

32

1 Comment

This past week, I virtually attended the World #Brain_Health_Summit: https://lnkd.in/dx2-NEwj, an enlightening event that delved into various facets of brain and mental health. It's crucial to understand the distinction between #brain_health and #mental_health. While interconnected, they represent distinct aspects of #well_being. #Mental_health encompasses conditions that influence one's thinking, emotions, mood, and behavior. On the other hand, #brain_health pertains to the absence of disease or impairment, coupled with optimal cognitive, emotional, and social functioning. Consider these eye-opening statistics 📢 : According to the #WHO, 1 in 3 individuals grapple with neurological disorders, while 1 in 4 contend with mental health challenges. #Neurological conditions stand as leading causes of disability and rank as the second-largest contributors to global mortality rates. #BrainHealth #MentalHealthAwareness #PublicHealth #well_being #Neurology #emotions

6

Quick tricks to improve patient care!

4

Dive deep into the psyche of physicians with our upcoming webinar on neuromarketing! ➡️ Join leading experts on May 30th to explore new methods of understanding HCP’s motivation and decision-making and elevate your marketing strategy. Register at https://bit.ly/3ydngV5 #HCPengagement #neuromarketing

1